These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 758857)

  • 1. Effects of aspirin and dextran on patency of bovine heterografts in the venous system.
    Ricotta JJ; Collins GJ; Rich NM
    Ann Surg; 1979 Jan; 189(1):116-9. PubMed ID: 758857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation inhibition in human umbilical vein grafts and negatively charged bovine heterografts.
    Feins RH; Roedersheimer R; Green RM; DeWeese JA
    Surgery; 1979 Apr; 85(4):395-9. PubMed ID: 432801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of aspirin and dextran for thromboprophylaxis in geriatric hip fracture patients.
    Feldman DS; Zuckerman JD; Walters I; Sakales SR
    J Orthop Trauma; 1993; 7(1):1-5. PubMed ID: 7679439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of isovolemic hemodilution with 3% albumin, dextran-40, and prophylactic enoxaparin (LMWH) on thrombus formation at venous microanastomosis in rats.
    Farina JA; Piccinato CE; Campos AD; Rossi MA
    Microsurgery; 2006; 26(6):456-64. PubMed ID: 16924631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of early vein graft thrombosis by drugs altering platelet function.
    Clagett GP; Zelenock GB; Stanley JC; Lindenauer SM; Fry WJ
    Surg Forum; 1973; 24():253-4. PubMed ID: 4806002
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of combined treatment with dextran 40 and acetylsalicylic acid on patency in severely traumatized small veins and arteries: an experimental study in the rabbit.
    Salemark L; Knudsen F; Dougan P
    J Reconstr Microsurg; 1996 May; 12(4):221-6. PubMed ID: 8723832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experimental evaluation of prophylaxis in venous thrombosis by the use of antiplatelet agents.
    O'Sullivan EF; Vellar ID
    Aust N Z J Surg; 1974 Nov; 44(4):415-20. PubMed ID: 4533895
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily.
    Harris WH; Athanasoulis CA; Waltman AC; Salzman EW
    J Bone Joint Surg Am; 1985 Jan; 67(1):57-62. PubMed ID: 2578469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep vein thrombosis after uncemented total hip replacement.
    Kim YH; Choi IY; Park MR; Park TS; Cho JL
    Bull Hosp Jt Dis; 1997; 56(3):133-9. PubMed ID: 9361912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of immunosuppression to prolong venous allograft survival.
    Ricotta JJ; Collins GJ; Rich NM; Reynolds DG
    Arch Surg; 1980 Jan; 115(1):99-101. PubMed ID: 7350895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect and clinical significance of low molecular weight and clinical dextran on an experimental venous thrombus in sheep.
    Johnson DC; Reeve TS
    Ann Surg; 1968 Jul; 168(1):123-7. PubMed ID: 5673188
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease.
    Jost CJ; Gloviczki P; Cherry KJ; McKusick MA; Harmsen WS; Jenkins GD; Bower TC
    J Vasc Surg; 2001 Feb; 33(2):320-7; discussion 327-8. PubMed ID: 11174784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dextran in thrombophlebitis experimental and clinical studies.
    Bryant MF; Bloom WL; Brewer SS
    Am Surg; 1966 Jan; 32(1):13-6. PubMed ID: 5900579
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
    Harris WH; Salzman EW; Athanasoulis C; Waltman AC; Baum S; DeSanctis RW
    J Bone Joint Surg Am; 1974 Dec; 56(8):1552-62. PubMed ID: 4434023
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of heparin and low molecular weight dextran on the patency of autogenous vein grafts in the venous system.
    Hobson RW; Croom RD; Rich NM
    Ann Surg; 1973 Dec; 178(6):773-6. PubMed ID: 4759408
    [No Abstract]   [Full Text] [Related]  

  • 17. Dimethylsulfoxide-treated, cryopreserved venous allografts in the arterial and venous systems.
    Sitzmann JV; Imbembo AL; Ricotta JJ; McManama GP; Hutchins GM
    Surgery; 1984 Feb; 95(2):154-9. PubMed ID: 6695333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of infusion therapy (including dextran) for venous thrombosis.
    Russell HE; Bradham RR; Lee WH
    Circulation; 1966 Jun; 33(6):839-46. PubMed ID: 5940514
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboprophylaxis after hip fracture: evaluation of 3 pharmacologic agents.
    Jeong GK; Gruson KI; Egol KA; Aharonoff GB; Karp AH; Zuckerman JD; Koval KJ
    Am J Orthop (Belle Mead NJ); 2007 Mar; 36(3):135-40. PubMed ID: 17461395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular vein-graft patency in the rat model.
    Zhang F; Oliva A; Kao SD; Newlin L; Buncke HJ
    J Reconstr Microsurg; 1994 Jul; 10(4):223-7. PubMed ID: 7965995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.